По алфавиту
Y Heike, M Takahashi, T Ohira, I Naruse, S Hama, Y Ohe, T Kasai, H Fukumoto, K J Olsen, E E Podack, N Saijo
Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma cellsInt J Cancer. 1997 Dec 10;73(6):844-9.
Y K Tam, H G Klingemann
Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantationBiol Blood Marrow Transplant. 1999;5(3):144-54.
Yang L.P., Perry C.M.
Histamine Dihydrochloride in the Management of Acute Myeloid Leukaemia.Drugs & Aging. 2011 January, Volume 71, Issue 1, pp 109–122.
Yang L.P., Perry C.M.
Spotlight on Histamine Dihydrochloride in Acute Myeloid Leukaemia.Drugs & Aging. 2011. 28: 325.
Yasumura S, Lin WC, Hirabayashi H, Vujanovic NL, Herberman RB, Whiteside TL.
Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.Cancer Res. 1994 Jul 15;54(14):3808-16. PMID: 8033100.
Yee Chung Cheng, Gabriela Rondón, Leah F Sanchez, John D McMannis, Daniel R Couriel, Marcos J de Lima, Chitra Hosing, Issa F Khouri, Sergio A Giralt, Richard E Champlin, Naoto T Ueno
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancerInt J Hematol. 2009 Dec;90(5):627-634.
Yee Chung Cheng, Gabriela Rondón, Leah F Sanchez, John D McMannis, Daniel R Couriel, Marcos J de Lima, Chitra Hosing, Issa F Khouri, Sergio A Giralt, Richard E Champlin, Naoto T Ueno
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancerInt J Hematol. 2009 Dec;90(5):627-634.
Yilmaz-Demirdag Y, Wilson B, Lowery-Nordberg M, Bocchini JA Jr, Bahna SL.
Interleukin-2 treatment for persistent cryptococcal meningitis in a child with idiopathic CD4(+) T lymphocytopenia.Allergy Asthma Proc. 2008 Jul-Aug;29(4):421-4.
Yodoi J, Tagaya Y, Masutani H, Maeda Y, Kawabe T.
IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor.Princess Takamatsu Symp. 1988;19:73-86. PMID: 2978620.
Yodoi J, Teshigawara K, Nikaido T et al.
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).J Immunol. 1985 Mar;134(3):1623-30. PMID: 2578514.
Yulian K., Gurveen K., Paul C. et al.
Abstract CT304: Anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 plus low-dose interleukin-2 (IL-2) in patients with recurrent prostate cancer (PC).DOI: 10.1158/1538-7445.AM2014-CT304 Published 1 October 2014.
В соответствии с п. 1 ст. 64 Федерального закона от 12.04.2010 № 61-ФЗ "Об обращении лекарственных средств" лекарственные препараты, находящиеся в обращении на территории Российской Федерации, подлежат мониторингу безопасности в целях выявления возможных негативных последствий их применения, предупреждения пациентов и их защиты от применения таких препаратов.